SRNE - Sorrento Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/9/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
1.53B376.40M567.16M280.34M327.43M
Enterprise Value 3
1.76B644.66M849.06M528.93M401.68M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
1.28N/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
34.368.2317.3011.2014.62
Price/Book (mrq)
15.134.7912.363.362.48
Enterprise Value/Revenue 3
53.3783.4965.1491.5462.02
Enterprise Value/EBITDA 6
-7.40-10.92-14.57-8.50-6.75

Trading Information

Stock Price History

Beta (5Y Monthly) 3.16
52-Week Change 3221.12%
S&P500 52-Week Change 34.59%
52 Week High 310.00
52 Week Low 31.39
50-Day Moving Average 35.48
200-Day Moving Average 33.56

Share Statistics

Avg Vol (3 month) 333.55M
Avg Vol (10 day) 326.09M
Shares Outstanding 5209.69M
Float 144.99M
% Held by Insiders 134.21%
% Held by Institutions 117.86%
Shares Short (Jun 14, 2020) 441.26M
Short Ratio (Jun 14, 2020) 40.56
Short % of Float (Jun 14, 2020) 420.14%
Short % of Shares Outstanding (Jun 14, 2020) 419.68%
Shares Short (prior month May 14, 2020) 423.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Jul 31, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-577.03%

Management Effectiveness

Return on Assets (ttm)-20.78%
Return on Equity (ttm)-337.39%

Income Statement

Revenue (ttm)33.01M
Revenue Per Share (ttm)0.22
Quarterly Revenue Growth (yoy)25.70%
Gross Profit (ttm)-87.68M
EBITDA -179.9M
Net Income Avi to Common (ttm)-249.19M
Diluted EPS (ttm)-1.95
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.9M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)255.01M
Total Debt/Equity (mrq)497.82
Current Ratio (mrq)0.55
Book Value Per Share (mrq)0.51

Cash Flow Statement

Operating Cash Flow (ttm)-167.24M
Levered Free Cash Flow (ttm)-114.95M